KTTA Pasithea Therapeutics Corp

$0.48

Pasithea Therapeutics Corp (KTTA) is expected to report earnings on November 13, 2026, after the market close. The consensus earnings estimate is a loss of $0.21 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +0.5% since its last earnings release on August 14, 2026.

Pasithea Therapeutics Reported In-line with Estimates
Earnings Date
3rd Quarter, Sep 2026
Nov 13
Friday · After Close
Earnings Whisper
-
vs ($0.21)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $0.54

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Pasithea Therapeutics Corp

Pasithea Therapeutics Corp. is a biotechnology company. It focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Pasithea Therapeutics Corp. is based in MIAMI BEACH, Fla.

Sector

Healthcare

Industry

Biotechnology